ALBBY vs ESNT
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
ALBBY · ALIBABA HEALTH INFORMATION TECH LTD UNSPON ADR EACH REPR 20 ORD SHS$7.70 ▲ 0.65%
ESNT · Essent$63.41 ▼ 7.57%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- ALBBY -44.1%
- ESNT +4.4%
Head to head
| Metric | ALBBY | ESNT |
|---|---|---|
| Price | $7.70 | $63.41 |
| Change today | ▲ 0.65% | ▼ 7.57% |
| Market cap | $5.70B | $5.70B |
| Return, 3 months | -7.0% | -5.7% |
| Return, year to date | -37.3% | -0.8% |
| Return, 1 year | -44.1% | +5.6% |
| P/E (TTM) | 22.6 | 8.8 |
| P/B | 2.3 | 1.0 |
| P/E percentile vs own 5y | – | 93rd |
| Dividend yield | 2.27% | 2.08% |
| Revenue growth (YoY, latest qtr) | – | +13.6% |
| Net profit growth (YoY) | – | -2.9% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | 50.4% |
| Return on equity | – | 12.0% |
| Analyst target vs. price | – | +13.8% |
| Analyst buy share | – | 29% |
| RSI (14) | 55 | 43 |
| 30-day volatility | 75.0% | 42.7% |
| Max drawdown, 1 year | -59.2% | -16.8% |
| Trend read | Leaning bullish | Leaning bearish |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- ESNT is the largest of the group by market value.
- ESNT has returned the most over the past year.
- ESNT carries the lowest trailing P/E.
- ALBBY pays the highest dividend yield.
- ESNT has been the calmest stock over the last 30 days.